Free | 1 month subscription available.
The Global Cancer Diagnostics Market Size was valued at USD 19.5 Billion in 2023, and it is expected to reach USD 54.6 Billion by 2032, growing at a CAGR of 12.1% during the forecast period (2023-2030).
Free | 1 month subscription available.
The Global Cancer Diagnostics Market Size was valued at USD 19.5 Billion in 2023, and it is expected to reach USD 54.6 Billion by 2032, growing at a CAGR of 12.1% during the forecast period (2023-2030).
Price $36,000 | 12 month subscription available.
Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations. Sourced from self-reported and de-identified data this product provides valuable insights about med combination trends.
Price $250 | 12 month subscription available.
Zip Propensity Data is derived from Prosper's US Monthly Consumer survey. The survey data is modeled to Zip Code level. Source data was collected in July 2020, during the Covid-19 Coronavirus Pandemic, capturing behavior changes and preferences of over 7,800 adults during the National Emergency....
Free | Publicly available
This dataset captures Sunflower's genetic diversity originating from thousands of wild, cultivated, and landrace sunflower individuals distributed across North America. The data consists of raw sequences and associated botanical metadata, aligned sequences (to three different reference genomes),...
Free | Publicly available
This a Parquet representation of the Open Targets Platform's [latest export](https://www.targetvalidation.org/downloads/data). The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease...
Free | 12 month subscription available.
This release contains 4 level smoking data from 1995 to 2010 in the United States, by region and by states or territory. Percentages are weighted to population characteristics.
Free | Publicly available
COVID-19 PubSeq is a free and open online bioinformatics public sequence resource with on-the-fly analysis of sequenced SARS-CoV-2 samples that allows for a quick turnaround in identification of new virus strains. PubSeq allows anyone to upload sequence material in the form of FASTA or FASTQ files...
Price $150 | 12 month subscription available.
In October 2012, CMS began reducing Medicare payments for Inpatient Prospective Payment System hospitals with excess readmissions. Excess readmissions are measured by a ratio, calculated by dividing a hospital’s number of “predicted” 30-day readmissions for heart attack (AMI), heart failure (HF),...
Price $7,999 | 12 month subscription available.
This data set is made up of highly realistic, but synthetic patient data that can be used for testing purposes without risk of disclosing PHI (protected health information). We offer bespoke synthetic data to meet your needs. Contact us for more information.
Price $30,000 | 12 month subscription available.
Healthcare Companies investment signals produced through a Bottom-Up approach starting from engagement and sentiment factors of companies’ drugs.
showing 131 - 140